Researchers say the breakthrough is an important step forward in being able to carry out medical research without the use of ...

Virginia Tech researchers have shown that memory loss in aging may be reversible. Using CRISPR tools, they corrected molecular disruptions in the hippocampus and amygdala, restoring memory in older ...

Confocal microscopy: visualized condensate formation in living cells, comparing normal CHD1 with the mutant form. CRISPR-Cas9 genome editing: engineered human cells carrying the E1321fs mutation to ...

Aziz Ansari, an award-winning actor, director, writer and comedian, brings his “Hypothetical Tour” to the Gallo Center. He co ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

Intellia Therapeutics finds itself navigating a significant crisis as regulatory developments overshadowed the release of its ...

Cathie Wood’s Ark Invest has made a series of portfolio adjustments. The firm trimmed exposure to several biotech companies ...

Cathie Wood's ARK Invest bought $17M in CRISPR and Beam gene-editing stocks while selling Teradyne, Roku, and SoFi shares on ...

Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...

A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

NEW YORK – Azalea Therapeutics launched on Tuesday, having raised $82 million in seed and Series A financing to develop in vivo genetic medicines for cancer and autoimmune conditions using its ...